ValiBIO is developing novel cancer diagnostic products in 3 main areas:
-
NucleosomicsTM blood tests for the early detection of cancer based on the presence of epigenetic alterations to the nucleosomes of blood in cancer patients
-
HypergenomicsTM tissue biopsy tests for the differential, prognostic and personalised medicine diagnostics of cancer based on the detection of epigenetic alterations in chromatin structure – hypersensitive sites
-
HPV diagnostic tests